KKR closed an all-cash acquisition of Integer Holdings for $5.7 billion, removing the medical device contract development and manufacturing organization from public markets in a single transaction. The deal prices Integer's specialized manufacturing footprint—cardiovascular rhythm management, neuromodulation, and orthopedic device assembly—at a premium to comparable publicly traded CDMOs, reflecting KKR's thesis that regulated production capacity commands infrastructure-like returns when paired with long-term OEM contracts.
Integer operates 28 manufacturing facilities across the United States, Mexico, Europe, and Asia, serving major medical device OEMs under multi-year supply agreements. The company generated roughly $1.6 billion in trailing revenue, with 72% derived from cardiovascular devices and the remainder split between orthopedic and portable medical components. KKR's purchase values Integer at approximately 3.6x trailing revenue, in line with recent private equity acquisitions of scaled manufacturing platforms in the life sciences sector. The firm paid cash, bypassing any equity rollover or earnout structure, a signal that KKR views Integer's contract book as stable enough to support leverage without operational risk-sharing.
The transaction matters because it confirms a structural shift in how private equity treats medical device supply chains. Integer is not a high-growth SaaS business or a distressed turnaround; it is a capital-intensive, margin-stable contract manufacturer with sticky customer relationships and regulatory barriers to entry. KKR's willingness to deploy $5.7 billion in equity and debt capital reflects a bet that device OEMs will continue to outsource complex manufacturing rather than build in-house capacity, especially as FDA and international regulatory requirements grow more onerous. Integer's existing customer base includes multi-billion-dollar medical technology companies locked into supply agreements that span product life cycles measured in decades, not quarters.
For allocators, the secondary implication is valuation compression in publicly traded CDMO peers. Integer's exit multiple sets a ceiling for comparable businesses still trading on public markets, particularly those without Integer's scale in cardiovascular manufacturing. The deal also removes a benchmark from the Russell 2000, reducing visibility into contract manufacturing economics for investors who track the sector through public comps. KKR's move follows a pattern: acquire a subscale but profitable industrial platform, apply operational improvements funded by lower-cost private capital, then hold or exit to a strategic buyer once margin expansion has been wrung out. Integer's 18% EBITDA margin leaves room for KKR to tighten procurement, consolidate facilities, and improve throughput without jeopardizing OEM relationships.
Operators should monitor whether KKR pushes Integer toward higher-mix neuromodulation manufacturing, a segment with better margins than cardiovascular rhythm management but shorter contract durations. Any shift in customer concentration—Integer's top 10 customers represent roughly 60% of revenue—would signal a strategic pivot rather than steady-state management. The deal also sets a comp for other mid-cap medical device suppliers considering take-private offers; expect banker pitches to reference Integer's exit multiple as a floor for negotiation. If KKR files to take Integer public again within 36 to 48 months, it will confirm that the firm saw this as a short-hold compression play rather than a long-duration infrastructure asset.
Integer's largest OEM customer, Medtronic, has not yet commented on supply continuity under KKR ownership, but contract provisions typically require advance notice of ownership changes and allow renegotiation of pricing terms. That conversation will determine whether KKR can hold margins or must concede economics to retain the contract book.
The takeaway
KKR's $5.7B all-cash Integer acquisition prices medical device manufacturing capacity as infrastructure, compressing comps for remaining public CDMOs.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.